紫杉醇是从红豆杉属植物体内提取的一种抗癌新药，随着美国、加拿大、瑞典、美国和我国正式批准上市[1]，其产业化开发进展很快。除现已批准可临床治疗晚期卵巢癌外，紫杉醇还有其它广泛用途。本文就紫杉醇产业化开发前景及其相关问题进行了综述和探讨。1前景与意义1.1治疗晚期 Paclitaxel, an anti-cancer drug extracted from the plants of Taxus, has been developed rapidly with the approval of the United States, Canada, Sweden, the United States and China. In addition to being approved for the clinical treatment of advanced ovarian cancer, paclitaxel has a wide range of other uses. This article reviews the prospects of paclitaxel industrialization and related issues. 1 prospects and significance 1.1 late treatment